Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert J. Van Gulick
Robert J. Van Gulick
Anschutz Medical Campus
Cancer research
Medicine
Melanoma
Immunotherapy
MHC class I
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
2021
Pharmaceuticals, policy and law
Chiara R. Dart
Nabanita Mukherjee
Carol M. Amato
Anabel Goulding
Morgan MacBeth
Robert J. Van Gulick
Kasey L. Couts
James R. Lambert
David A. Norris
William A. Robinson
Yiqun G. Shellman
Show All
Source
Cite
Save
Citations (0)
Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma.
2021
Journal of Clinical Oncology
Martin D. McCarter
Richard P. Tobin
Dasha T Cogswell
Victoria M. Vorwald
Dana Davis
Robert J. Van Gulick
Kasey L. Couts
Kimberly R. Jordan
Victoria Nuanes
Dexiang Gao
Theresa Medina
Karl D. Lewis
Rene Gonzalez
Ross W. McFarland
William A. Robinson
Show All
Source
Cite
Save
Citations (1)
Targeting the RIG-I-like receptor signaling pathway to improve the efficacy of immunotherapy in mucosal and uveal melanoma.
2021
Journal of Clinical Oncology
Morgan MacBeth
Robert J. Van Gulick
Richard P. Tobin
Dasha T Cogswell
Theresa Medina
Martin D. McCarter
William A. Robinson
Kasey L. Couts
Show All
Source
Cite
Save
Citations (0)
Circulating CD8+ MAIT cells correlate with improved outcomes in anti-PD1 treated melanoma patients.
2020
medRxiv
Victoria M. Vorwald
Dana Davis
Robert J. Van Gulick
Robert J. Torphy
Jessica S. W. Borgers
Jared Klarquist
Kasey L. Couts
Carol M. Amato
Dasha T Cogswell
Mayumi Fujita
Timothy Davis
Catherine A. Lozupone
Theresa Medina
William A. Robinson
Laurent Gapin
Martin D. McCarter
Richard P. Tobin
Show All
Source
Cite
Save
Citations (0)
1
map